EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cushing disease in a patient with multiple endocrine neoplasia type 2B

Kannan Kasturi, Lucas Fernandes, Martha Quezado, Mary Eid, Leigh Marcus, Prashant Chittiboina, Mark Rappaport, Constantine A Stratakis, Brigitte Widemann, Maya Lodish

Journal of Clinical and Translational Endocrinology: Case Reports · 2017

DOI: 10.1016/j.jecr.2017.02.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical and Translational Endocrinology: Case Reports, 2017. Verfasst von Kannan Kasturi und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Child Health & Human Development, National Institutes of Health (NIH), Building 10-CRC, room 1-3330 10 Center Drive Bethesda MD…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Laboratory of Pathology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CONTEXT: Multiple endocrine neoplasia type 2B (MEN2B) is a rare autosomal-dominant cancer syndrome characterized in part by metastatic medullary thyroid cancer (MTC) and pheochromocytoma. Cushing disease is a rare cause of endogenous hypercortisolism in children. CASE DESCRIPTION: We describe a 21-year-old African-American male who was diagnosed at age 10 with an ACTH-secreting pituitary microadenoma. At age 16 he developed medullary thyroid cancer and was found to have multiple endocrine neoplasia type 2B with the characteristic M918T mutation of the RET proto-oncogene. Following thyroidectomy, he was initiated on Vandetanib, a tyrosine kinase inhibitor, and has since had stable disease over the last 5 years. CONCLUSIONS: Our patient is the first individual with MEN2B to be described with Cushing disease. The RET oncogene may play a role in pituitary tumorigenesis; alternatively, the coexistence of these two entities may represent an extremely rare coincidence.

Schlagwörter

Stichwörter der Autor:innen

HypercortisolemiaRETgenetic syndromeneuroendocrine tumor

Autor:innen und Institutionen

  • National Institute of Child Health & Human Development, National Institutes of Health (NIH), Building 10-CRC, room 1-3330 10 Center Drive Bethesda MD 20892.
  • Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892.
  • Pediatric Oncology Branch, National Cancer Institute, NIH Bethesda, MD 20892.
  • Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, NIH Bethesda MD 20892.
  • Children's Healthcare of Atlanta, Atlanta GA 30144.

Förderung

  • Intramural NIH HHS
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Laboratory of Pathology
  • Center for Cancer Research
  • National Cancer Institute
  • National Institutes of Health, Bethesda, MD

Zitieren

APA

Kasturi, K., Fernandes, L., Quezado, M., Eid, M., Marcus, L., Chittiboina, P., Rappaport, M., Stratakis, C. A., Widemann, B., & Lodish, M. (2017). Cushing disease in a patient with multiple endocrine neoplasia type 2B. Journal of Clinical and Translational Endocrinology: Case Reports. https://doi.org/10.1016/j.jecr.2017.02.001

Vancouver

Kasturi K, Fernandes L, Quezado M, Eid M, Marcus L, Chittiboina P, et al. Cushing disease in a patient with multiple endocrine neoplasia type 2B. Journal of Clinical and Translational Endocrinology: Case Reports. 2017. doi:10.1016/j.jecr.2017.02.001

BibTeX
@article{Kasturi2017,
  author = {Kasturi, Kannan and Fernandes, Lucas and Quezado, Martha and Eid, Mary and Marcus, Leigh and Chittiboina, Prashant and Rappaport, Mark and Stratakis, Constantine A and Widemann, Brigitte and Lodish, Maya},
  title = {Cushing disease in a patient with multiple endocrine neoplasia type 2B},
  journal = {Journal of Clinical and Translational Endocrinology: Case Reports},
  year = {2017},
  doi = {10.1016/j.jecr.2017.02.001}
}
Kostenlos starten →